Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

EXtubasjonsrelaterte komplikasjoner - EXTUBE-studien (EXTUBE) (EXTUBE)

19. oktober 2026 oppdatert av: University Health Network, Toronto

EXtubasjonsrelaterte komplikasjoner - en internasjonal observasjonsstudie for å forstå virkningen og beste praksis i operasjonsrommet og intensivavdelingen - EXTUBE-studien

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Studieoversikt

Status

Rekruttering

Forhold

Detaljert beskrivelse

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

Studietype

Observasjonsmessig

Registrering (Antatt)

3000

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • New South Wales
      • Sydney, New South Wales, Australia, 2065
        • Fullført
        • Royal North Shore Hospital
    • Victoria
      • Melbourne, Victoria, Australia, 3135
        • Fullført
        • Eastern Health - Maroondah Hospital
      • Melbourne, Victoria, Australia, 3156
        • Fullført
        • Eastern Health - Angliss Hospital
      • Melbourne, Victoria, Australia, 3076
        • Fullført
        • The Northern Hospital
      • Melbourne, Victoria, Australia, 3128
        • Fullført
        • Eastern Health - Box Hill Hospital
      • Melbourne, Victoria, Australia, 3084
        • Fullført
        • Austin Health - Austin Hospital
      • Melbourne, Victoria, Australia, 3079
        • Fullført
        • Austin Health - Heidelberg Repatriation Hospital
    • British Columbia
      • Surrey, British Columbia, Canada, V3V 1Z2
        • Fullført
        • Surrey Memorial Hospital
    • New Brunswick
      • Moncton, New Brunswick, Canada, E1C 4B7
        • Fullført
        • The Moncton Hospital
    • Ontario
      • North York, Ontario, Canada, M4N 3M5
        • Fullført
        • Sunnybrook Hospital
      • Saint Catharines, Ontario, Canada, L2S 0A9
        • Fullført
        • Niagara Health - Marotta Family Hospital
      • Toronto, Ontario, Canada, M5B 1W8
        • Fullført
        • St. Michael's Hospital
      • Toronto, Ontario, Canada, M5G 1X5
        • Fullført
        • Mount Sinai Hospital
      • Toronto, Ontario, Canada, M5G 2C4
        • Rekruttering
        • University Health Network - Toronto General Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matteo Parotto, MD, PhD
        • Ta kontakt med:
        • Underetterforsker:
          • Alicia Grassi, MD
      • Toronto, Ontario, Canada, M5T 2S8
        • Fullført
        • University Health Network - Toronto Western Hospital
    • Quebec
      • Montreal, Quebec, Canada, H2X 0C1
        • Fullført
        • Centre hospitalier de l'Université de Montréal (CHUM)
      • Piedecuesta, Colombia
        • Fullført
        • Hospital Internacional de Colombia
    • Arizona
      • Tucson, Arizona, Forente stater, 85724-5114
        • Fullført
        • Banner University Medical Centre
    • Arkansas
      • Little Rock, Arkansas, Forente stater, 72205
        • Fullført
        • University of Arkansas for Medical Sciences
    • Florida
      • Gainesville, Florida, Forente stater, 32608
        • Fullført
        • University of Florida
    • Illinois
      • Chicago, Illinois, Forente stater, 60637
        • Fullført
        • The University of Chicago
    • Oregon
      • Portland, Oregon, Forente stater, 97239
        • Fullført
        • Oregon Health & Science University
    • Texas
      • Houston, Texas, Forente stater, 77030
        • Fullført
        • The University of Texas Health Science Center
      • Castlebar, Irland, F23 H529
        • Fullført
        • Mayo University Hospital
      • Cork, Irland, T12 DFK4
        • Fullført
        • Cork University Hospital
      • Dublin, Irland, D07 R2WY
        • Fullført
        • Mater Misericordiae University Hospital
      • Galway, Irland, H91 YR71
        • Fullført
        • Galway University Hospitals
      • Waterford, Irland, X91 ER8E
        • Har ikke rekruttert ennå
        • University Hospital Waterford
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
        • Underetterforsker:
          • Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
      • Kuwait City, Kuwait
        • Fullført
        • Amiri Hospital
      • Auckland, New Zealand, 1023
        • Fullført
        • Auckland City Hospital
      • Invercargill, New Zealand, 9812
        • Fullført
        • Southland Hospital
      • Rotorua, New Zealand, 3010
        • Fullført
        • Rotorua Hospital
      • Singapore, Singapore, 308433
        • Fullført
        • Tan Tock Seng Hospital
      • Bath, Storbritannia, BA1 3NG
        • Fullført
        • Royal United Hospitals Bath
      • Newcastle upon Tyne, Storbritannia, NE7 7DN
        • Fullført
        • Freeman Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).

Beskrivelse

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion Criteria:

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
Tidsramme: Within 60 minutes after the end of extubation

The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation:

i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Within 60 minutes after the end of extubation

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Difficult airway and complications related to airway management if reintubation is required
Tidsramme: Within 60 minutes after the end of extubation

Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required

Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
Tidsramme: Within 60 minutes after the end of extubation

Planned and unplanned non-invasive respiratory support or high flow nasal cannula

Within 60 minutes after the end of extubation
Emergency front of neck airway
Tidsramme: Within 60 minutes after the end of extubation

Emergency front of neck airway should airway management be required after extubation

Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
Tidsramme: Within 60 minutes after the end of extubation

Cardiac arrhythmia requiring chemical or electrical treatment

Within 60 minutes after the end of extubation
Severe Hypotension
Tidsramme: Within 60 minutes after the end of extubation

Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg)

Within 60 minutes after the end of extubation
Severe Hypertension
Tidsramme: Within 60 minutes after the end of extubation

Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg),

Within 60 minutes after the end of extubation
Pulmonary aspiration
Tidsramme: Within 60 minutes after the end of extubation

Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract)

Within 60 minutes after the end of extubation
Barotrauma
Tidsramme: Within 60 minutes after the end of extubation

Pneumothorax/pneumo-mediastinum

Within 60 minutes after the end of extubation
Dental injury
Tidsramme: Within 60 minutes after the end of extubation

Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required)

Within 60 minutes after the end of extubation
Airways injury
Tidsramme: Within 60 minutes after the end of extubation

Airways injury (e.g., vocal cord damage, arytenoid dislocation

Within 60 minutes after the end of extubation
Mortality
Tidsramme: Within 7 days after extubation

In-hospital mortality

Within 7 days after extubation
Re-intubation
Tidsramme: Within 48 hours after extubation

Re-intubation within 48 hours of extubation

Within 48 hours after extubation

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Matteo Parotto, MD, PhD, UHN

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

14. april 2025

Primær fullføring (Antatt)

1. desember 2027

Studiet fullført (Antatt)

1. desember 2027

Datoer for studieregistrering

Først innsendt

28. mars 2024

Først innsendt som oppfylte QC-kriteriene

3. juni 2024

Først lagt ut (Faktiske)

5. juni 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

22. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. oktober 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 24-5811
  • 4850 (Annen identifikator: Clinical Trials Ontario - CTO)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere